Products

What will AGI do for Atiprosin maleate?

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H29N3.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50SZ4782J0, chemically known as pyrazino(2,3:3,4)pyrido(1,2-a)indole, 1-ethyl-1,2,3,4,4a,5,6,12b-octahydro-12-methyl-4-(1-methylethyl)-, trans- but more generally known as atiprosin maleate, which bears US NIH Compound Identifier 3034029. Most nations, for tariff and trade purposes, schedule atiprosin maleate under HS 29335995 and SITC 51576. As of Q4 2014, ATIPROSIN MALEATE remains US FDA's Preferred Term for this commodity. Atiprosin maleate bears US NLM identifiers UMLS ID C0104775 and NCI Concept Code C87434. SMILES: CCN1CCN([C@H]2[C@H]1C3C(C4CCCCC4N3CC2)C)C(C)C.C(=C\C(=O)O)\C(=O)O.

How AGI delivers it

Four ways AGI delivers for Atiprosin maleate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Atiprosin maleate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Atiprosin maleate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Atiprosin maleate connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Particle Size Distributionmodel
  • Residual Solventmodel